Platelet Concentration Systems Market to Surpass US$ 1,110.4 Million by 2027 - Coherent Market Insights

Global Platelet Concentration Systems Market, by Technology (Apheresis Technology, Single Spin Technology, and Double Spin Technology), by End User (Hospital, Orthopedic Clinics, Sports Injury Centers, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 286.99 million in 2020 and is expected to exhibit a CAGR of 21.2%  during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

The global platelet concentration systems market is expected to witness significant growth during the forecast period, owing to the increasing number of product approvals and launches by key players. For instance, in 2018, Bellus Medical, a leader in medical aesthetics, launched progen PRP system used in areas of orthopedics, wound care, aesthetics, cardiovascular, and pain management, to accelerate tissue synthesis and provide a faster and more efficient healing process.

Furthermore, in August 2019, Healeon Medical, Inc., a wholly owned subsidiary of Bimini Health Tech, received the U.S FDA 510 (K) clearance approval for its Healeon Duet (BK200449), a novel blood separation system for platelet rich plasma (PRP) preparation.

Global Platelet Concentration Systems Market - Impact of Coronavirus (Covid-19) Pandemic

Platelet concentration systems are designed for safe and rapid preparation of platelet rich plasma at the point of care from a small amount of patient’s blood sample.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to more 100 countries around the globe with the World Health Organization declaring it a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus disease (COVID-19) has resulted in more than 63.3 million infected individuals worldwide as of 30 November 2020.

COVID-19 can affect the global economy in three main ways; by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. Due to the lockdown, many countries such as Italy, Spain, U.K., the U.S., Australia, India, and others are facing problems with regards to the supply and demand side of Platelet Concentration Systems

Browse 26 Market Data Tables and 27 Figures spread through 157 Pages and in-depth TOC on Platelet Concentration Systems Market, by Technology (Apheresis Technology, Single Spin Technology, and Double Spin Technology), by End User (Hospital, Orthopedic Clinics, Sports Injury Centers, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Forecast to 2027"

To know the latest trends and insights related to platelet concentration systems market, click the link below:

https://www.coherentmarketinsights.com/market-insight/platelet-concentration-systems-market-4324

Key Takeaways of the Platelet Concentration Systems Market:

• The global platelet concentration systems market is expected to exhibit a CAGR of 21.2% during the forecast period (2020-2027), owing to increasing launches and approval of platelet concentration systems
• Among technology, the apheresis technology segment is expected to hold a major revenue share in 2027. Apheresis is a medical technique in which the blood of a patient or donor is extracted and separated into components such as red cells, white cells, plasma, and platelets.
• Major players operating in the global platelet concentration systems market include Anthrax Inc., Stryker Corporation, Johnson & Johnson’s, Zimmer Biomet Holdings Inc., Terumo Corporation, Arteriocyte Medical Systems, Inc., Exactech Inc., Harvest Technologies Corp., and Nuo Therapeutics, Inc.